Who Paid My Doc
Colaris
Device Germline Dna Sequencing Hereditary Cancer And Rearrangement Analysis
General payments
$5,843
Research payments
$0
Through program year 2022, $5,843 in general payments and $0 in research payments were reported against Colaris (Germline Dna Sequencing Hereditary Cancer And Rearrangement Analysis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $854 | 13 |
| 2021 | General | $4,989 | 12 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
25 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.